Resalis Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 8

Resalis Therapeutics General Information

Description

Developer of non-coding RNA-based therapeutics designed to address metabolic disorders such as obesity and fatty liver disease. The company's platform leverages expertise in lipid metabolism and RNA modalities, enabling doctors to use a disease-modifying approach to treat metabolic dysfunction with its lead candidate.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Ettore de Sonnaz 19
  • 10121 Turin
  • Italy
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Via Ettore de Sonnaz 19
  • 10121 Turin
  • Italy

Resalis Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resalis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 28-Oct-2024 Completed Clinical Trials - Phase 1
4. Early Stage VC (Series A) 05-Jan-2024 Completed Pre-Clinical Trials
3. Accelerator/Incubator Completed Pre-Clinical Trials
2. Seed Round 15-Feb-2023 $10.8M $17.9M Completed Pre-Clinical Trials
1. Seed Round 05-Aug-2021 $7.1M $7.1M Completed Pre-Clinical Trials
To view Resalis Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Resalis Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-coding RNA-based therapeutics designed to address metabolic disorders such as obesity and fatty liver d
Drug Discovery
Turin, Italy
9 As of 2024

Charlottesville, VA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Resalis Therapeutics Competitors (1)

One of Resalis Therapeutics’s competitors is HemoShear Therapeutics, a Venture Capital-Backed company based in Charlottesville, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HemoShear Therapeutics Venture Capital-Backed Charlottesville, VA
You’re viewing 1 of 1 competitors. Get the full list »

Resalis Therapeutics Patents

Resalis Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4807003-A1 Method and compounds to address ageing Pending 10-Mar-2025
WO-2026190663-A1 Methods and compounds to address ageing Pending 10-Mar-2025
EP-4353823-A1 Inhibitors of micro-rna 22 Pending 12-Oct-2022
JP-2024057599-A Inhibitors of micro-rna 22 Pending 12-Oct-2022
US-12691135-B2 Inhibitors of micro-rna 22 Active 14-Mar-2018 A61K31/7125
To view Resalis Therapeutics’s complete patent history, request access »

Resalis Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resalis Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sanofi Corporation Minority
Sunstone Life Science Ventures Venture Capital Minority
Angel (individual) Minority
B-Engine Venture Capital Minority
Claris Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Resalis Therapeutics FAQs

  • When was Resalis Therapeutics founded?

    Resalis Therapeutics was founded in 2021.

  • Where is Resalis Therapeutics headquartered?

    Resalis Therapeutics is headquartered in Turin, Italy.

  • What is the size of Resalis Therapeutics?

    Resalis Therapeutics has 9 total employees.

  • What industry is Resalis Therapeutics in?

    Resalis Therapeutics’s primary industry is Drug Discovery.

  • Is Resalis Therapeutics a private or public company?

    Resalis Therapeutics is a Private company.

  • What is Resalis Therapeutics’s current revenue?

    The current revenue for Resalis Therapeutics is .

  • How much funding has Resalis Therapeutics raised over time?

    Resalis Therapeutics has raised $28.9M.

  • Who are Resalis Therapeutics’s investors?

    Sanofi, Sunstone Life Science Ventures, , B-Engine, and Claris Ventures are 5 of 8 investors who have invested in Resalis Therapeutics.

  • Who are Resalis Therapeutics’s competitors?

    HemoShear Therapeutics is a competitor of Resalis Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process